Lerner P, Goodwin F K, van Kammen D P, Post R M, Major L F, Ballenger J C, Lovenberg W
Biol Psychiatry. 1978 Dec;13(6):685-94.
The activity of dopamine-beta-hydroxylase (DBH) in cerebrospinal fluid (CSF) from 59 psychiatric patients has been analyzed by a highly sensitive radio-enzymatic assay. There was no sex difference in DBH, but there was a significant positive correlation with age. Probenecid administration had no effect on CSF DBH. DBH in CSF correlated positively (r = 0.60) with the plasma enzyme. Among patients hospitalized for major depressive disorder, unipolar or bipolar, schizo-affective disorder, schizophrenia, alcoholism, or personality disorders there were no significant between-group differences. Among the patients with bipolar affective disorder, DBH activity from manic patients was significantly lower than that from depressed or euthymic patients. The results are discussed with reference to the theory that the amount of DBH in CSF may serve as an indicator of central noradrenergic activity.
采用高灵敏度放射酶分析法对59例精神科患者脑脊液(CSF)中多巴胺-β-羟化酶(DBH)的活性进行了分析。DBH不存在性别差异,但与年龄呈显著正相关。丙磺舒给药对脑脊液DBH无影响。脑脊液中的DBH与血浆酶呈正相关(r = 0.60)。在因重度抑郁症、单相或双相情感障碍、分裂情感性障碍、精神分裂症、酒精中毒或人格障碍住院的患者中,组间无显著差异。在双相情感障碍患者中,躁狂患者的DBH活性显著低于抑郁或心境正常患者。结合脑脊液中DBH含量可作为中枢去甲肾上腺素能活性指标的理论对结果进行了讨论。